NCT02990624

Cardiovascular Risk Evaluation in Psoriasis Treated With Photochemotherapy

Effect of Photochemotherapy on Cardiometabolic Markers in Patients With Psoriasis With and Without Atherosclerosis

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 65 (actual)
• Sponsor: Cairo University · Academic / Other
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

Ultraviolet (UV) phototherapy is a standard treatment for many inflammatory dermatological diseases, including psoriasis. The systemic effects of UV phototherapy are still not well studied. There are several factors that may affect patient's cardiovascular (CV) risk during UV phototherapy. Atherosclerosis is now known to have an inflammatory origin and to be frequently associated with psoriasis. In this study the investigators aim at studying the effect of psoralen-UVA phototherapy on several biomarkers of CV risk in patients with psoriasis with or without atherosclerosis.

Conditions

• Psoriasis Vulgaris

Interventions

Type	Name	Description
RADIATION	PUVA	36 sessions of psoralen-ultraviolet A, divided as 3 sessions weekly

Timeline

• Start date: 2014-04-01
• Primary completion: 2015-09-01
• Completion: 2015-10-01
• First posted: 2016-12-13
• Last updated: 2016-12-13

Locations

1 site across 1 country: Egypt